Effects of toothpaste containing inactivated Lacticaseibacillus paracasei Probio-01 on plaque-induced gingivitis and dental plaque microbiota

• Published in: Microbial pathogenesis Vol. 192; p. 106701
• Main Authors: Li, Xinyi, Zhao, Zhixin, Guo, Shuai, Yang, Chengcong, Gao, Ying, Li, Lixian, Ning, Kegong, Zhang, Qiuxia, Zhou, Ni, Zhang, Heping, Li, Yanhong
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.07.2024
• Subjects: Adult; Dental plaque; Dental Plaque - microbiology; Dental Plaque Index; Female; Fusobacterium; Gingiva - microbiology; Gingiva - pathology; gingivitis; Gingivitis - microbiology; Humans; Inactivated Lacticaseibacillus paracasei Probio-01; inflammation; Leptotrichia; Male; Microbiota - drug effects; Microbiota analysis; microorganisms; Middle Aged; mouth; Oral microbiota; pathogenesis; Periodontal Index; Plaque-induced gingivitis; Probiotics - administration & dosage; Probiotics - therapeutic use; RNA, Ribosomal, 16S - genetics; toothpaste; Toothpastes - therapeutic use; Young Adult; Dental plaque; Oral microbiota; Plaque-induced gingivitis; Inactivated Lacticaseibacillus paracasei Probio-01; Microbiota analysis
• ISSN: 0882-4010; 1096-1208; 1096-1208
• DOI: 10.1016/j.micpath.2024.106701

Plaque-induced gingivitis is an inflammatory response in gingival tissues resulting from bacterial plaque accumulation at the gingival margin. Postbiotics can promote the proliferation of beneficial bacteria and optimise the state of microbiota in the oral cavity. In this study, we investigated the effect of inactivated Lacticaseibacillus paracasei Probio-01 on plaque-induced gingivitis and the dental plaque microbiota. A total of 32 healthy gingival participants (Group N, using blank toothpaste for 3 months) and 60 patients with plaque-induced gingivitis (30 in Group F, using inactivated Probio-01 toothpaste for 3 months, and 30 in Group B, using blank toothpaste for 3 months, respectively) were recruited. Clinical indices, which included bleeding on probing (BOP), gingival index (GI), and plaque index (PI), were used to assess the severity of gingivitis. Furthermore, 16SrDNA amplicon sequencing was used to explore changes in the gingival state and dental plaque microbiota in patients with plaque-induced gingivitis. The results showed that inactivated Probio-01 significantly reduced clinical indices of gingivitis, including BOP, GI, and PI, in participants with plaque-induced gingivitis and effectively relieved gingival inflammation, compared with that observed in the control group (group B). Inactivated Probio-01 did not significantly influence the diversity of dental plaque microbiota, but increased the relative abundance of dental plaque core bacteria, such as Leptotrichia and Fusobacterium (P < 0.05). Strong correlations were observed between the indices and abundance of dental plaque microbiota. Overall, the inactivated Probio-01 significantly reduced the clinical indices of gingivitis and effectively improved gingival inflammation in patients with plaque-induced gingivitis. The activity of inactivated Probio-01 against plaque-induced gingivitis was possibly mediated by its ability to regulate the dental plaque microbiota, as indicated by the close correlation between the plaque microbiota and clinical indices of gingivitis. •Probiotics may be used as adjuvant treatment to control the plaque-induced gingivitis.•Inactivated Probio-01 significantly reduced the clinical indices of gingivitis and effectively improved the gingival inflammation.•Inactivated Probio-01 may alleviate plaque-induced gingivitis by regulating dental plaque microbiota.